AbbVie is a research-based global biopharmaceutical company. The mission of the company is to discover and develop transformative therapies that deliver compelling patient benefits, strong clinical performance and clear economic value, while reshaping the standard of care for patients. In 2013, AbbVie became a separate company from Abbott (founded in 1888), though sharing a common legacy and strong prospects for future success.
In 2018, AbbVie medicines helped over 30 million patients in more than 175+ countries. More than 30 000 employees work in the company worldwide. AbbVie is a leader in immunology. The company has been leveraging deep scientific expertise to develop next-generation biologics and small molecules in rheumatology, dermatology and gastroenterology. Oncology is the fastest growing therapeutic area from AbbVie’s portfolio. AbbVie may have been founded in 2013, but its roots run deep.